Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 2
2004 5
2005 5
2006 10
2007 11
2008 12
2009 12
2010 12
2011 24
2012 26
2013 28
2014 25
2015 35
2016 25
2017 19
2018 23
2019 25
2020 20
2021 21
2022 32
2023 33
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

344 results

Results by year

Filters applied: . Clear all
Page 1
Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors.
Hayashi Y, Makino T, Sato E, Ohshima K, Nogi Y, Kanemura T, Honma K, Yamashita K, Saito T, Tanaka K, Yamamoto K, Takahashi T, Kurokawa Y, Miyata H, Nakajima K, Wada H, Morii E, Eguchi H, Doki Y. Hayashi Y, et al. Among authors: miyata h. Br J Cancer. 2023 Jun;128(12):2175-2185. doi: 10.1038/s41416-023-02235-9. Epub 2023 Apr 4. Br J Cancer. 2023. PMID: 37016103 Free PMC article.
Exploring the Multifaceted Nexus of Uric Acid and Health: A Review of Recent Studies on Diverse Diseases.
Kuwabara M, Fukuuchi T, Aoki Y, Mizuta E, Ouchi M, Kurajoh M, Maruhashi T, Tanaka A, Morikawa N, Nishimiya K, Akashi N, Tanaka Y, Otani N, Morita M, Miyata H, Takada T, Tsutani H, Ogino K, Ichida K, Hisatome I, Abe K. Kuwabara M, et al. Among authors: miyata h. Biomolecules. 2023 Oct 13;13(10):1519. doi: 10.3390/biom13101519. Biomolecules. 2023. PMID: 37892201 Free PMC article. Review.
Perioperative therapy for esophageal cancer.
Yamasaki M, Miyata H, Miyazaki Y, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y. Yamasaki M, et al. Among authors: miyata h. Gen Thorac Cardiovasc Surg. 2014 Sep;62(9):531-40. doi: 10.1007/s11748-014-0458-y. Epub 2014 Jul 29. Gen Thorac Cardiovasc Surg. 2014. PMID: 25065567 Review.
Multimodal treatment for resectable esophageal cancer.
Miyata H, Yamasaki M, Kurokawa Y, Takiguchi S, Nakajima K, Fujiwara Y, Mori M, Doki Y. Miyata H, et al. Gen Thorac Cardiovasc Surg. 2011 Jul;59(7):461-6. doi: 10.1007/s11748-011-0780-6. Epub 2011 Jul 14. Gen Thorac Cardiovasc Surg. 2011. PMID: 21751104 Review.
Chemoradiotherapy versus triplet chemotherapy as initial therapy for T4b esophageal cancer: survival results from a multicenter randomized Phase 2 trial.
Yamasaki M, Miyata H, Yamashita K, Hamakawa T, Tanaka K, Sugimura K, Makino T, Takeno A, Shiraishi O, Motoori M, Kimura Y, Hirao M, Fujitani K, Yasuda T, Yano M, Eguchi H, Doki Y. Yamasaki M, et al. Among authors: miyata h. Br J Cancer. 2023 Jul;129(1):54-60. doi: 10.1038/s41416-023-02286-y. Epub 2023 May 4. Br J Cancer. 2023. PMID: 37142731 Free PMC article. Clinical Trial.
Perioperative Ghrelin Administration Attenuates Postoperative Skeletal Muscle Loss in Patients Undergoing Esophagectomy for Esophageal Cancer: Secondary Analysis of a Randomized Controlled Trial.
Nose Y, Yamashita K, Takeoka T, Momose K, Saito T, Tanaka K, Yamamoto K, Makino T, Takahashi T, Kurokawa Y, Yamasaki M, Shiraishi O, Miyata H, Yasuda T, Yano M, Eguchi H, Doki Y. Nose Y, et al. Among authors: miyata h. Ann Surg Oncol. 2022 Jun;29(6):3604-3612. doi: 10.1245/s10434-022-11436-0. Epub 2022 Feb 20. Ann Surg Oncol. 2022. PMID: 35187621 Clinical Trial.
Clinical Impact of Enhanced Recovery After Esophagectomy in Patients With Esophageal Cancer.
Sugase T, Kanemura T, Takeoka T, Urakawa S, Sugimura K, Masuike Y, Shinno N, Hara H, Omori T, Kitakaze M, Kubo M, Mukai Y, Sueda T, Hasegawa S, Akita H, Nishimura J, Wada H, Yasui M, Miyata H. Sugase T, et al. Among authors: miyata h. Anticancer Res. 2023 Sep;43(9):4197-4205. doi: 10.21873/anticanres.16611. Anticancer Res. 2023. PMID: 37648293
[Adjuvant treatment for esophagogastric junction cancer].
Kurokawa Y, Takiguchi S, Miyazaki Y, Takahashi T, Yamasaki M, Miyata H, Nakajima K, Mori M, Doki Y. Kurokawa Y, et al. Among authors: miyata h. Nihon Geka Gakkai Zasshi. 2015 Jan;116(1):50-4. Nihon Geka Gakkai Zasshi. 2015. PMID: 25842814 Review. Japanese.
Gut microbiota associated with the mitigation effect of synbiotics on adverse events of neoadjuvant chemotherapy in patients with esophageal cancer: A retrospective exploratory study.
Sugimoto T, Atobe S, Kado Y, Takahashi A, Motoori M, Sugimura K, Miyata H, Yano M, Tanaka K, Doki Y, Shiraishi O, Yasuda T, Asahara T. Sugimoto T, et al. Among authors: miyata h. J Med Microbiol. 2023 Jun;72(6). doi: 10.1099/jmm.0.001723. J Med Microbiol. 2023. PMID: 37367942 Clinical Trial.
344 results